Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100000 participants
OBSERVATIONAL
2021-10-14
2031-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
US National OCS Heart Perfusion (OHP) Registry
NCT05915299
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
NCT03639025
US National TOP Registry
NCT06513091
Trial of the TransMedics Organ Care System™ Liver For Preserving and Assessing Donor Livers for Transplantation
NCT02449694
Data Collection Study From Donors and Recipients to Optimize Donor-recipient Matching in Liver Transplantation
NCT03371264
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OCS Liver Transplant Recipients
The US National OLP Registry will enroll all liver transplant recipients who are transplanted with an OCS-perfused donor liver in the Registry.
OCS Liver
The TransMedics® Organ Care System (OCS) Liver is an FDA approved portable extracorporeal liver perfusion and monitoring system.
Non-OCS Liver Transplant Recipients
Patients transplanted using other preservation modalities for clinical outcomes.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCS Liver
The TransMedics® Organ Care System (OCS) Liver is an FDA approved portable extracorporeal liver perfusion and monitoring system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TransMedics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Elbetanony, MD
Role: STUDY_DIRECTOR
TransMedics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama
Birmingham, Alabama, United States
Mayo Clinic Hospital Arizona
Phoenix, Arizona, United States
University of California San Diego
La Jolla, California, United States
University of California San Francisco
San Francisco, California, United States
Mayo Clinic Hospital Florida
Jacksonville, Florida, United States
Emory University Hospital
Atlanta, Georgia, United States
University of Kentucky Medical Center
Lexington, Kentucky, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Lahey Clinic Medical Center
Burlington, Massachusetts, United States
University of Michigan Medical Center
Ann Arbor, Michigan, United States
Henry Ford Hospital
Detroit, Michigan, United States
Mayo Clinic Hospital Minnesota
Rochester, Minnesota, United States
SSM Health Saint Louis University Hospital
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
NY Presbyterian Hospital/Columbia Univ. Medical Center
New York, New York, United States
Carolinas Medical Center/Atrium Health
Charlotte, North Carolina, United States
Duke Medical Center
Durham, North Carolina, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
UT Southwestern Medical Center
Dallas, Texas, United States
Houston Methodist
Houston, Texas, United States
University Hospital, University of Texas Health Science Center
San Antonio, Texas, United States
University of Utah Medical Center
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Leigh McManus
Role: primary
Dakota Hohenwalter
Role: primary
Denya Arellano
Role: primary
Joanne Kwan
Role: primary
Jessica Toukmehji
Role: primary
Jeryl Huckaby
Role: primary
Deepa Valvi
Role: primary
Madelyn Subocz
Role: primary
Kirsten Peterson
Role: primary
Nicholas Demchuk
Role: primary
Matthew Callaghan
Role: primary
Iman Francis
Role: backup
Candy Peterman
Role: primary
Craig Dedert
Role: primary
Michelle Leahy
Role: primary
Rachel Nuccitelli
Role: primary
Katheryn Peterson
Role: primary
Jerry Turner
Role: primary
Willa Meyer
Role: primary
Morgan Marsh
Role: primary
Deborah Pokrass
Role: primary
Jillian Woodworth
Role: primary
Chinedu Nwaduru, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OCS-LIVER-OLP-II
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.